“Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287)”. SKIN The Journal of Cutaneous Medicine 9, no. 4 (July 23, 2025): s588. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/3533.